Pfizer asks FDA to authorize booster shots for kids ages 5 through 11
Data show that a third dose can help boost kids' immunity. Some experts are skeptical that another shot is needed for younger kids.
pfizer
Moderna says its new 'bivalent' vaccine shows promise against COVID variants
The company says this version targets both the original coronavirus and the beta variant, and appears to provide broader and longer-lasting protection against different strains, including omicron.
Pfizer-BioNTech will seek authorization for second COVID booster for older adults
Pfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older.
The FDA postpones a highly anticipated meeting on the Pfizer vaccine for young kids
"We believe additional information regarding the ongoing evaluation of a third dose should be considered as part of our decision-making for potential authorization," FDA officials said in a statement.
Feds' contract with Pfizer for Paxlovid has some surprises
NPR has obtained the government's $5.3 billion contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.
Pfizer and BioNTech begin testing an omicron-specific COVID-19 vaccine
Though people who are vaccinated and boosted appear to be better protected against omicron, the highly contagious variant has still led to breakthrough cases and a surge in infections worldwide.
Booster longevity: Data reveals how long a third shot protects
Now researchers in the U.K. have the first estimates for how long a third shot of the Pfizer vaccine will last. The findings are mixed.
FDA authorizes 1st antiviral pill for COVID
In a highly anticipated decision, the Food and Drug Administration authorized Pfizer's Paxlovid as the first antiviral pill to treat COVID-19 at home.
Coronavirus FAQ: What does it mean if the booster knocks me out? What if it doesn't?
Vaccine and booster side effects can include fever, aches and fatigue. And this may be the first vaccine in history where people complain if they don't experience side effects, says one doctor.
Studies suggest sharp drop in vaccine protection vs. omicron — yet cause for optimism
In small studies in South Africa and in Germany, the results indicate a marked decrease in the ability of vaccines to neutralize this variant. But there are other findings that are encouraging.